RDIF and ChemRar to supply Avifavir to 17 countries

Efficacy of favipiravir-based drugs against COVID-19 confirmed by clinical trials in Russia and Japan Avifavir already delivered to Belarus, Bolivia, Kazakhstan, Kyrgyzstan, Turkmenistan and Uzbekistan, deliveries to 17 more countries expected MOSCOW, Sept. 24, 2020 /PRNewswire/ — The Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, and ChemRar Group have agreed to supply Avifavir, […]

Read more

RDIF and ChemRar to Deliver 60,000 Courses of the First COVID-19 Drug Registered in Russia, Avifavir, to the Country’s Hospitals in June

– Global landmark in the successful treatment of COVID-19 – Avifavir is the first direct-acting antiviral drug registered in Russia that has proven effective against COVID-19 in clinical trials – Avifavir has become the first Favipiravir-based drug in the world approved for the treatment of COVID-19 MOSCOW, June 1, 2020 /PRNewswire/ — The Russian Direct […]

Read more

RDIF and ChemRar Announce First Interim Results of Clinical Trials of Favipiravir Drug’s Effectiveness in Coronavirus Therapy

MOSCOW, May 13, 2020 /PRNewswire/ — The Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, and the ChemRar Group today announce the positive first interim results of the multicenter randomized open comparative clinical trial of the drug Favipiravir on patients hospitalized with COVID-19. According to the data received, 60% of the 40 patients who […]

Read more

RDIF and Mubadala Invest in Leading Russian Fitness Chain World Class

MOSCOW, November 28, 2018/PRNewswire/ –A consortium of investors including the Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, Abu Dhabi’s Mubadala Investment Company, and other leading Middle Eastern investment funds have announced investments in Russian Fitness Group (RFG), which manages the largest chain of fitness clubs in Russia under the ‘World Class’ brand. The […]

Read more